Dogs impacted by chronic kidney disease (CKD) can live more manageable lives thanks to a new study from experts at the Koret School of Veterinary Medicine at Hebrew University. Typically affecting older dogs, new research studies the benefits of paricalcitol, a drug used for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney failure.
The study, led by Koret’s Dr. Hila Chen, recently published in the Journal of Veterinary Internal Medicine, explores the possibility that paricalcitol may effectively reduce the force of secondary hyperparathyroidism coming from the disease.
Pariacalcitol is a type of vitamin D and is believed to be a positive way to manage CKD complications.
CKD is a disease where a dog’s kidneys gradually lose their ability to function. It mostly…